To sum up, there is a positive feedback loop between ARF6 and ERK1/2, leading to the promotion of proliferation and tumorigenesis in pancreatic cancer by amplifying the oncogenic effect of KRAS. Here, ARF6 is linked to pancreatic neoplasm.